Actively Recruiting
MEASUREMENT OF CIRCULATING MUTATION BURDEN
Led by Centre Francois Baclesse · Updated on 2025-07-08
30
Participants Needed
1
Research Sites
129 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cancer-free women with a hereditary predisposition to breast and/or ovarian cancer
CONDITIONS
Official Title
MEASUREMENT OF CIRCULATING MUTATION BURDEN
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female participant
- Participant undergoing oncogenetic follow-up at the Centre François Baclesse
- Participant belonging to a pair of related biological siblings
- One sibling is a carrier of a hereditary predisposition linked to a BRCA1/2 mutation, and the other sibling is not a carrier
- Participant between 30 and 50 years of age
- Participant affiliated to a social security scheme
- Participant has given informed consent prior to study procedures
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre François Baclesse
Caen, France, France
Actively Recruiting
Research Team
L
Louise May THIBAUT, Medical Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here